Search
for
Sort by
Research 541–570 of 767
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Concurrent autoimmune and endocrine dysregulation in polycystic ovary syndrome
- Exploring Hirsutism: Epidemiology, Associated Endocrinal Abnormalities, and Societal Challenges in GCC—A Narrative Review
- The impact of type 2 diabetes on polycystic ovary syndrome in patients undergoing sleeve gastrectomy
- Association of insulin resistance with polycystic ovary syndrome phenotypes and patients’ characteristics: a cross-sectional study in Iran
- Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden
- Polycystic ovary syndrome in Singapore
- Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome
- Case Report: Successful Use of Minoxidil to Promote Facial Hair Growth in an Adolescent Transgender Male
- An Indian Evidence-Based Study of Prevalence, Phenotypic Features, Lifestyle Modifications of Polycystic Ovarian Syndrome Patients
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- The Relationship between Serum Levels of Anti-Mullerian Hormone and Body Mass Index in Adolescents with Polycystic Ovary Syndrome
- Nonclassical Congenital Adrenal Hyperplasia and Pregnancy
- Gut microbiota variation in admixed Hispanic populations with polyendocrine metabolic ovarian syndrome
- Metabolic dysfunction in women with PCOS is more closely linked to BMI than to hyperandrogenism
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Sexual Dysfunction in Polycystic Ovary Syndrome (PCOS): A Biopsychosocial Approach to Assessment and Management
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Evaluation of dihydrotestosterone levels and total testosterone to dihydrotestosterone ratio with clinical symptoms and metabolic parameters in patients with polycystic ovary syndrome
- Polycystic ovary syndrome: pragmatic management across levels of care
- Postmenopausal ovarian hyperandrogenism of surgically treated patients: a case report and scoping review with individual patient’s data analysis
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Androgens and Hirsutism in a Large Cohort of Portuguese Women
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome
- A Complex Clinical Situation in Polycystic Ovary Syndrome: HAIR‐AN Syndrome ‘‘Case Report’’
- Rare Conditions of Hyperandrogenism Through Lifespan: A Case Series